title: [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
authors.forename: A
authors.initials: A
authors.lastname: Branchi
authors.forename: D
authors.initials: D
authors.lastname: Sommariva
authors.forename: M
authors.initials: M
authors.lastname: Tirrito
authors.forename: D
authors.initials: D
authors.lastname: Bonfiglioli
authors.forename: C
authors.initials: C
authors.lastname: Pini
authors.forename: L
authors.initials: L
authors.lastname: Scandiani
authors.forename: S
authors.initials: S
authors.lastname: Orlandi
authors.forename: A
authors.initials: A
authors.lastname: Fasoli
mesh_terms: D001054:Apolipoproteins A / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood*; D001629:Bezafibrate / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
chemical_list: D001054:Apolipoproteins A; D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol; D001629:Bezafibrate
vernacular_title: Effetti del bezafibrato sui lipidi lipoproteici e sulle apolipoproteine B e A1 di pazienti con ipercolesterolemia primitiva.